Seungkyu Park

Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab)

G. Bou-Assaf, J. Hong, Yuh-Chuang Lee, 2016, mAbs.

Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.

E. Kurbatova, M. L. van der Walt, C. Kvasnovsky, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Drifts in ADCC-related quality attributes of Herceptin®: Impact on development of a trastuzumab biosimilar

Jinsu Song, S. Ham, Seokkyun Kim, 2017, mAbs.

Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.

Carmen Z. Suarez, E. Kurbatova, M. L. van der Walt, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.

Carmen Z. Suarez, E. Kurbatova, M. L. van der Walt, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.